MG4101 Plus Rituximab Including Lymphodepletion in Patient With r/r NHL B-cell Origin

weekly administration of Rituximab 375mg/m2 during cycle 1 and 2, monthly administration from cycle 3(up to cycle 6)

administration of fludarabine 20mg/m2 for 3 consecutive days starting at 3 days before the 1st, 3rd, and 5th cycle of the first rituximab infusion for that cycle

administration of fludarabine 250mg/m2 for 3 consecutive days starting at 3 days before the 1st, 3rd, and 5th cycle of the first rituximab infusion for that cycle

administration every fortnight for each cycle, beginning with the 1st dose of rituximab for that cycle.

1 x 10\^6 IU/m2, together with MG4101